P0444 Frequency and Characteristics of Anorectal Pathologies in Patients with Inflammatory Bowel Disease
Authors: Contreras Aviles E , Philippe Ponce M , Guinea Lagunes A , Almeida del Prado G , Sebastian Ocampo V , López Perez R , Jiménez Bobadilla B , De Leon Rendon J L 
Published: January 2025

Background

Inflammatory Bowel Disease (IBD), comprising Crohn’s disease (CD) and ulcerative colitis (UC), commonly manifests with gastrointestinal symptoms such as diarrhea and abdominal pain. Anorectal complications are more prevalent in CD and less frequent in UC. In CD, perianal involvement is a significant clinical concern, with the development of abscesses and fistulas that can complicate disease management. Additionally, benign anorectal conditions such as hemorrhoids and fissures are commonly observed. Managing anorectal pathologies in IBD is complex and may require anything from topical medications to surgery in severe cases. A comprehensive approach is essential to address both intestinal symptoms and perianal complications. The aim of this study is to describe the frequency and characteristics of anorectal pathologies in patients with IBD from the IBD Clinic of the General Hospital of Mexico "Dr. Eduardo Liceaga".

Methods

In a retrospective observational study at the IBD Clinic of the Hospital General de Mexico, 184 patients with IBD were analyzed over 12 months. Clinical and demographic data, diagnoses, treatments, and anorectal pathologies were evaluated. SPSS version 29 was used for statistical analysis, highlighting measures of central tendency, frequency distribution, and the Chi-square test for inferential analysis.

Results

In our study, the demographic and clinical characteristics of patients with IBD were evaluated, highlighting that 31.5% had anorectal pathologies (ARP). The most common among these were hemorrhoidal disease (16.8%), fistulas (6%), and anal fissure (3.3%). In the subgroup of patients with UC and ARP (n=46), males predominated (52.2%) with an average age of 40.13 years. Hemorrhoids (56.5%) were the most common ARP. In the group with CD and ARP (n=12), females predominated (83.3%) with an average age of 45.75 years, with fistulas (50%) being the most prevalent ARP. Medical treatment was effective in most cases (91.3% in UC, 75% in CD), with a small percentage requiring surgical treatment. No statistically significant differences were found in the characteristics between the IBD groups with and without ARP (p &gt; 0.05).

Conclusion

The study highlighted a high prevalence of anorectal pathologies (31.5%) in patients with IBD, including hemorrhoidal disease, fistulas, and anal fissures. Differences in incidence were observed according to the type of IBD, with a higher presence of fistulas in CD. Most patients responded well to medical treatment, although some required surgery. These results underline the importance of comprehensive approaches in the management of IBD, focusing on adequately evaluating and treating perianal complications to improve quality of life.

References

Misselwitz B, Rickenbacher A, Brand S. Klinik, Diagnostik und Therapie proktologischer Beschwerden bei Patienten mit chronisch entzündlichen Darmerkrankungen. Therapeutische Umschau. Revue therapeutique. 2021;78(9):547-558. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1024/0040-5930/a001309

Truong A, Zaghiyan K, Fleshner P. Anorectal Crohn’s Disease. Surg Clin North Am. 2019;99(6):1151-1162. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1016/j.suc.2019.08.012

D’Ugo S, Stasi E, Gaspari AL, Sileri P. Hemorrhoids and anal fissures in inflammatory bowel disease. Minerva Gastroenterol Dietol. 2015;61(4):223-233. Hamzaoglu I, Hodin RA. Perianal problems in patients with ulcerative colitis. Inflamm Bowel Dis. 2005;11(9):856-859. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1097/01.mib.0000174373.75977.b9

Xu S, Zhang L, Li Z, et al. Enhancing surgical precision: unveiling the impact of preoperative colonoscopy in anal fistula patients. BMC Gastroenterol. 2023;23:442. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1186/s12876-023-03066-x

Yamamoto T, Allan RN, Keighley MR. Effect of fecal diversion alone on perianal Crohn’s disease. World J Surg. 2000;24(10):1258-1263. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1007/s002680010250

Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Infliximab maintenance therapy for fistulizing Crohn’s disease. N Engl J Med. 2004;350(9):876-885. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1056/NEJMoa030815

Márquez Velásquez JR, González Awique PS, Miranda Ruíz CA, Muñoz Zuluaga M, Miranda Ruíz LF. Uso de la anoscopia de alta resolución para la detección de displasia anal por papilomavirus en pacientes con enfermedad inflamatoria intestinal. Rev Colomb Gastroenterol. 2023;38(4):419-2. [citado 2024 Aug 29]. Disponible en: https://revistagastrocol.com/index.php/rcg/article/view/1048

El-Gazzaz G, Hull T, Church JM. Biological immunomodulators improve the healing rate in surgically treated perianal Crohn’s fistulas. Colorectal Dis. 2012;14(10):1217-1223. [citado 2024 Aug 29]. Disponible en: https://doi.org/10.1111/j.1463-1318.2012.02944.x

Gold SL, Cohen-Mekelburg S, Schneider Y, Steinlauf A. Perianal fistulas in patients with Crohn’s disease, part 1: current medical management. Gastroenterol Hepatol (N Y). 2018;14(8):470-481. Smith RK, Paulson EC. Perianal fistulas in patients with inflammatory bowel disease. Semin Colon Rectal Surg. 2014;25(4):216-220.